Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction

被引:76
作者
Goldberg, A
Hammerman, H
Petcherski, S
Zdorovyak, A
Yalonetsky, S
Kapeliovich, M
Agmon, Y
Markiewicz, W
Aronson, D
机构
[1] Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
[2] Rappaport Med Sch, Haifa, Israel
关键词
D O I
10.1016/j.amjmed.2004.03.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: To determine the prevalence and prognostic implications of hyponatremia in the setting of acute ST-elevation myocardial infarction. METHODS: The study sample consisted of 1047 consecutive patients presenting with acute ST-elevation myocardial infarction. Plasma sodium concentrations were obtained on admission and at 24, 48, and 72 hours thereafter. Infarct size was determined by echocardiographic examination that was performed on day 2 or 3 of hospitalization. RESULTS: Hyponatremia, defined as a plasma sodium level < 135 mmol/L (< 135 mEq/L), was present on admission in 131 patients (12.5%). and developed during the first 72 hours of hospitalization in 208 patients (19.9%). Plasma sodium levels decreased to less than or equal to 130 mmol/L in 45 patients (4.3%). In a multivariate logistic regression analysis, hyponatremia was independently associated with 30-day mortality. The risk of 30-day mortality associated with hyponatremia on admission (odds ratio [OR] = 2.0; 95% confidence interval [0]: 1.0 to 3.9; P = 0.04) was similar to that of hyponatremia developing after admission (OR = 2.4; 95% CI: 1.5 to 4.2; P = 0.002). The risk of 30-day mortality increased with the severity of hyponatremia, with an odds ratio of 2.1 in patients with sodium levels between 130 and 134 mmol/L (95% CI: 1.2 to 3.5; P = 0.007) and 3.4 in those with levels < 130 mmol/L (95% CI: 1.5 to 7.8; P = 0.002). CONCLUSION: Hyponatremia on admission or early development of hyponatremia in patients with acute ST-elevation myocardial infarction is an independent predictor of 30-day mortality, and prognosis worsens with the severity of hyponatremia. Further studies are required to determine if plasma sodium levels may serve as a simple marker to identify patients at highrisk. (C) 2004 by Elsevier Inc.
引用
收藏
页码:242 / 248
页数:7
相关论文
共 33 条
[11]   HYPERGLYCEMIA-INDUCED HYPONATREMIA - CALCULATION OF EXPECTED SERUM SODIUM DEPRESSION [J].
KATZ, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (16) :843-844
[12]   SEVERE HYPONATREMIA IN HOSPITAL INPATIENTS [J].
KENNEDY, PGE ;
MITCHELL, DM ;
HOFFBRAND, BI .
BRITISH MEDICAL JOURNAL, 1978, 2 (6147) :1251-1253
[13]   ARGININE VASOPRESSIN GENE-EXPRESSION IN CHRONIC CARDIAC-FAILURE IN RATS [J].
KIM, JK ;
MICHEL, JB ;
SOUBRIER, F ;
DURR, J ;
CORVOL, P ;
SCHRIER, RW .
KIDNEY INTERNATIONAL, 1990, 38 (05) :818-822
[14]   HYPONATREMIA AS OBSERVED IN A CHRONIC DISEASE FACILITY [J].
KLEINFELD, M ;
CASIMIR, M ;
BORRA, S .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1979, 27 (04) :156-161
[15]   Comparing AMI mortality among hospitals in patients 65 years of age and older - Evaluating methods of risk adjustment [J].
Krumholz, HM ;
Chen, J ;
Wang, YF ;
Radford, MJ ;
Chen, YT ;
Marciniak, TA .
CIRCULATION, 1999, 99 (23) :2986-2992
[16]   Sodium [J].
Kumar, S ;
Berl, T .
LANCET, 1998, 352 (9123) :220-228
[17]   PREDICTORS OF 30-DAY MORTALITY IN THE ERA OF REPERFUSION FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM AN INTERNATIONAL TRIAL OF 41 021 PATIENTS [J].
LEE, KL ;
WOODLIEF, LH ;
TOPOL, EJ ;
WEAVER, WD ;
BETRIU, A ;
COL, J ;
SIMOONS, M ;
AYLWARD, P ;
VANDEWERF, F ;
CALIFF, RM .
CIRCULATION, 1995, 91 (06) :1659-1668
[18]  
LEE WH, 1986, CIRCULATION, V73, P257, DOI 10.1161/01.CIR.73.2.257
[19]   A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy [J].
Morrow, DA ;
Antman, EM ;
Giugliano, RP ;
Cairns, R ;
Charlesworth, A ;
Murphy, SA ;
de Lemos, JA ;
McCabe, CH ;
Braunwald, E .
LANCET, 2001, 358 (9293) :1571-1575
[20]   TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation - An intravenous nPA for treatment of infarcting myocardium early II trial substudy [J].
Morrow, DA ;
Antman, EM ;
Charlesworth, A ;
Cairns, R ;
Murphy, SA ;
de Lemos, JA ;
Giugliano, RP ;
McCabe, CH ;
Braunwald, E .
CIRCULATION, 2000, 102 (17) :2031-2037